Argus Investors' Counsel, Inc. Bio Techne Corp Transaction History

Argus Investors' Counsel, Inc.

$148 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 18, 2023	BUY	$80.67 - $352.29 $1.04 Million - $4.54 Million	12,895 Added 306.22%	17,106 $0
Q3 2022 Oct 18, 2022	BUY	$282.54 - $391.85 $19,495 - $27,037	69 Added 1.67%	4,211 $1.2 Million
Q2 2022 Jul 22, 2022	BUY	$322.67 - $449.65 $27,749 - $38,669	86 Added 2.12%	4,142 $1.44 Million
Q1 2022 May 04, 2022	BUY	$353.85 - $487.79 $153,217 - $211,213	433 Added 11.95%	4,056 $1.76 Million
Q4 2021 Jan 25, 2022	BUY	$456.15 - $525.06 $156,003 - $179,570	342 Added 10.42%	3,623 $1.87 Million
Q3 2021 Oct 20, 2021	BUY	$444.87 - $538.88 $98,761 - $119,631	222 Added 7.26%	3,281 $1.59 Million
Q2 2021 Jul 30, 2021	BUY	$387.35 - $450.26 $37,572 - $43,675	97 Added 3.27%	3,059 $1.38 Million
Q1 2021 Apr 19, 2021	SELL	$314.62 - $411.0 $104,768 - $136,863	-333 Reduced 10.11%	2,962 $1.13 Million
Q4 2020 Jan 27, 2021	BUY	$246.9 - $321.87 $15,060 - $19,634	61 Added 1.89%	3,295 $1.05 Million
Q3 2020 Oct 30, 2020	BUY	$232.22 - $282.96 $55,036 - $67,061	237 Added 7.91%	3,234 $801,000
Q2 2020 Jul 27, 2020	BUY	$185.43 - $279.56 $93,642 - $141,177	505 Added 20.26%	2,997 $791,000
Q1 2020 Apr 24, 2020	BUY	$161.17 - $221.51 $10,959 - $15,062	68 Added 2.81%	2,492 $473,000
Q4 2019 Jan 17, 2020	BUY	$189.68 - $222.09 $30,728 - $35,978	162 Added 7.16%	2,424 $532,000
Q3 2019 Oct 17, 2019	SELL	$183.56 - $216.72 $12,114 - $14,303	-66 Reduced 2.84%	2,262 $443,000
Q2 2019 Jul 10, 2019	SELL	$188.72 - $215.43 $439,340 - $501,521	-2,328 Reduced 50.0%	2,328 $485,000
Q2 2019 Jul 10, 2019	BUY	$188.72 - $215.43 $433,867 - $495,273	2,299 Added 97.54%	4,656 $971,000
Q1 2019 Apr 16, 2019	SELL	$136.09 - $200.44 $5,987 - $8,819	-44 Reduced 1.83%	2,357 $468,000
Q4 2018 Feb 06, 2019	BUY	$132.75 - $203.8 $41,949 - $64,400	316 Added 15.16%	2,401 $347,000
Q3 2018 Oct 16, 2018	BUY	$147.44 - $204.11 $307,412 - $425,569	2,085 New	2,085 $0

Others Institutions Holding TECH

# of Institutions

598

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.97B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.

Account